GLP-1 drugs are increasingly used for pre-conception weight management in women with obesity, despite limited safety data for this context.
Off-label useGLP-1 drugs increasingly used pre-conception for weight management despite limited pregnancy safety guidelines
What the researchers found
GLP-1 drugs are being used off-label for pre-conception weight management, but safety data for this specific context remains limited.
Why it matters
With millions of reproductive-age women now taking GLP-1 drugs, understanding pre-conception implications is urgent.
The numbers in context
No specific efficacy data from pre-conception trials; reviews observational and animal safety data.
How the study worked
Narrative review of PubMed, Medline, and Embase literature on GLP-1 RA use before and during pregnancy.
Who was studied
Women of reproductive age with obesity considering pregnancy
What this study cannot tell us
Narrative review — evidence base is sparse. Most pregnancy exposure data comes from inadvertent rather than planned use.
How to read the evidence
Narrative review — summarizes limited available evidence. No randomized trials of pre-conception GLP-1 use exist.
When this study was published
Published in 2025, addressing a rapidly emerging clinical question.
The bigger picture
This represents a growing tension between the proven benefits of pre-conception weight loss and the unknown risks of GLP-1 drug exposure near conception.
Questions still open
- How long before conception should GLP-1 drugs be stopped?
- Does pre-conception GLP-1 use improve pregnancy outcomes despite drug discontinuation?
Common questions
Can I take a GLP-1 drug before getting pregnant?
How long before pregnancy should I stop GLP-1 medication?
Read the original research
Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review.
Archives of gynecology and obstetrics, 311(5), 1241-1247
Citation
Price, Sarah A L; Nankervis, Alison. (2025). Considering the use of GLP-1 receptor agonists in women with obesity prior to pregnancy: a narrative review.. Archives of gynecology and obstetrics, 311(5), 1241-1247. https://doi.org/10.1007/s00404-024-07849-9